[1] |
CARDON A, CONCHON S, RENAND A. Mechanisms of autoimmune hepatitis[J]. Curr Opin Gastroenterol, 2021, 37( 2): 79- 85. DOI: 10.1097/MOG.0000000000000704.
|
[2] |
DALEKOS GN, SAMAKIDOU A, LYBEROPOULOU A, et al. Recent advances in the diagnosis and management of autoimmune hepatitis[J]. Pol Arch Intern Med, 2022, 132( 9): 16334. DOI: 10.20452/pamw.16334.
|
[3] |
OLIVAS I, RODRÍGUEZ-TAJES S, LONDOÑO MC. Autoimmune hepatitis: Challenges and novelties[J]. Med Clin(Barc), 2022, 159( 6): 289- 298. DOI: 10.1016/j.medcli.2022.04.004.
|
[4] |
SIRBE C, SIMU GL, SZABO I, et al. Pathogenesis of autoimmune hepatitis-cellular and molecular mechanisms[J]. Int J Mol Sci, 2021, 22( 24): 13578. DOI: 10.3390/ijms222413578.
|
[5] |
SONG WZ, CRAFT J. T follicular helper cell heterogeneity: Time, space, and function[J]. Immunol Rev, 2019, 288( 1): 85- 96. DOI: 10.1111/imr.12740.
|
[6] |
SCHROEDER AR, ZHU FM, HU H. Stepwise Tfh cell differentiation revisited: New advances and long-standing questions[J]. Fac Rev, 2021, 10: 3. DOI: 10.12703/r/10-3.
|
[7] |
NANCE JP, BÉLANGER S, JOHNSTON RJ, et al. Bcl6 middle domain repressor function is required for T follicular helper cell differentiation and utilizes the corepressor MTA3[J]. Proc Natl Acad Sci U S A, 2015, 112( 43): 13324- 13329. DOI: 10.1073/pnas.1507312112.
|
[8] |
GENSOUS N, CHARRIER M, DULUC D, et al. T follicular helper cells in autoimmune disorders[J]. Front Immunol, 2018, 9: 1637. DOI: 10.3389/fimmu.2018.01637.
|
[9] |
KHANAM A, AYITHAN N, TANG L, et al. IL-21-deficient T follicular helper cells support B cell responses through IL-27 in patients with chronic hepatitis B[J]. Front Immunol, 2021, 11: 599648. DOI: 10.3389/fimmu.2020.599648.
|
[10] |
POWELL MD, READ KA, SREEKUMAR BK, et al. IL-12 signaling drives the differentiation and function of a TH1-derived TFH1-like cell population[J]. Sci Rep, 2019, 9( 1): 13991. DOI: 10.1038/s41598-019-50614-1.
|
[11] |
MESAS-FERNÁNDEZ A, BODNER E, HILKE FJ, et al. Interleukin-21 in autoimmune and inflammatory skin diseases[J]. Eur J Immunol, 2023, 53( 4): e2250075. DOI: 10.1002/eji.202250075.
|
[12] |
ZANDER R, KASMANI MY, CHEN Y, et al. Tfh-cell-derived interleukin 21 sustains effector CD8+ T cell responses during chronic viral infection[J]. Immunity, 2022, 55( 3): 475- 493. DOI: 10.1016/j.immuni.2022.01.018.
|
[13] |
SHI JW, HOU SY, FANG Q, et al. PD-1 controls follicular T helper cell positioning and function[J]. Immunity, 2018, 49( 2): 264- 274. DOI: 10.1016/j.immuni.2018.06.012.
|
[14] |
TANEMURA S, TSUJIMOTO H, SEKI N, et al. Role of interferons(IFNs) in the differentiation of T peripheral helper(Tph) cells[J]. Int Immunol, 2022, 34( 10): 519- 532. DOI: 10.1093/intimm/dxac026.
|
[15] |
PAPILLION A, POWELL MD, CHISOLM DA, et al. Inhibition of IL-2 responsiveness by IL-6 is required for the generation of GC-TFH cells[J]. Sci Immunol, 2019, 4( 39): eaaw7636. DOI: 10.1126/sciimmunol.aaw7636.
|
[16] |
CROTTY S. T follicular helper cell biology: A decade of discovery and diseases[J]. Immunity, 2019, 50( 5): 1132- 1148. DOI: 10.1016/j.immuni.2019.04.011.
|
[17] |
WANG YF, SHI JW, YAN JC, et al. Germinal-center development of memory B cells driven by IL-9 from follicular helper T cells[J]. Nat Immunol, 2017, 18( 8): 921- 930. DOI: 10.1038/ni.3788.
|
[18] |
PAPA I, SALIBA D, PONZONI M, et al. TFH-derived dopamine accelerates productive synapses in germinal centres[J]. Nature, 2017, 547( 7663): 318- 323. DOI: 10.1038/nature23013.
|
[19] |
MARSMAN C, VERSTEGEN NJ, STREUTKER M, et al. Termination of CD40L co-stimulation promotes human B cell differentiation into antibody-secreting cells[J]. Eur J Immunol, 2022, 52( 10): 1662- 1675. DOI: 10.1002/eji.202249972.
|
[20] |
GARDELL JL, PARKER DC. CD40L is transferred to antigen-presenting B cells during delivery of T-cell help[J]. Eur J Immunol, 2017, 47( 1): 41- 50. DOI: 10.1002/eji.201646504.
|
[21] |
MICHEL NA, ZIRLIK A, WOLF D. CD40L and its receptors in atherothrombosis-an update[J]. Front Cardiovasc Med, 2017, 4: 40. DOI: 10.3389/fcvm.2017.00040.
|
[22] |
LU J, WU J, XIE FT, et al. CD4+ T cell-released extracellular vesicles potentiate the efficacy of the HBsAg vaccine by enhancing B cell responses[J]. Adv Sci(Weinh), 2019, 6( 23): 1802219. DOI: 10.1002/advs.201802219.
|
[23] |
FERNÁNDEZ-MESSINA L, RODRÍGUEZ-GALÁN A, DE YÉBENES VG, et al. Transfer of extracellular vesicle-microRNA controls germinal center reaction and antibody production[J]. EMBO Rep, 2020, 21( 4): e48925. DOI: 10.15252/embr.201948925.
|
[24] |
MA L, QIN JJ, JI HF, et al. Tfh and plasma cells are correlated with hypergammaglobulinaemia in patients with autoimmune hepatitis[J]. Liver Int, 2014, 34( 3): 405- 415. DOI: 10.1111/liv.12245.
|
[25] |
MORITA R, SCHMITT N, BENTEBIBEL SE, et al. Human blood CXCR5+CD4+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion[J]. Immunity, 2011, 34( 1): 108- 121. DOI: 10.1016/j.immuni.2010.12.012.
|
[26] |
ABE K, TAKAHASHI A, IMAIZUMI H, et al. Interleukin-21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis[J]. Springerplus, 2016, 5( 1): 777. DOI: 10.1186/s40064-016-2512-y.
|
[27] |
MA L, ZHANG LW, ZHUANG Y, et al. Lactobacillus improves the effects of prednisone on autoimmune hepatitis via gut microbiota-mediated follicular helper T cells[J]. Cell Commun Signal, 2022, 20( 1): 83. DOI: 10.1186/s12964-021-00819-7.
|
[28] |
WANG WJ, SUNG N, GILMAN-SACHS A, et al. T helper(Th) cell profiles in pregnancy and recurrent pregnancy losses: Th1/Th2/Th9/Th17/Th22/tfh cells[J]. Front Immunol, 2020, 11: 2025. DOI: 10.3389/fimmu.2020.02025.
|
[29] |
ZHANG R, ZHAO Y, CHEN X, et al. Low-dose IL-2 therapy in autoimmune diseases: An update review[J]. Int Rev Immunol, 2024, 43( 3): 113- 137. DOI: 10.1080/08830185.2023.2274574.
|
[30] |
KIMURA N, YAMAGIWA S, SUGANO T, et al. Usefulness of chemokine C-C receptor 7-/programmed cell death-1+ follicular helper T cell subset frequencies in the diagnosis of autoimmune hepatitis[J]. Hepatol Res, 2019, 49( 9): 1026- 1033. DOI: 10.1111/hepr.13356.
|
[31] |
CHENG ZL, YANG L, CHU HK. The gut microbiota: A novel player in autoimmune hepatitis[J]. Front Cell Infect Microbiol, 2022, 12: 947382. DOI: 10.3389/fcimb.2022.947382.
|
[32] |
DING TT, SU R, WU RH, et al. Frontiers of autoantibodies in autoimmune disorders: Crosstalk between tfh/tfr and regulatory B cells[J]. Front Immunol, 2021, 12: 641013. DOI: 10.3389/fimmu.2021.641013.
|
[33] |
LINTERMAN MA, PIERSON W, LEE SK, et al. Foxp3+ follicular regulatory T cells control the germinal center response[J]. Nat Med, 2011, 17( 8): 975- 982. DOI: 10.1038/nm.2425.
|
[34] |
CHUNG Y, TANAKA S, CHU FL, et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions[J]. Nat Med, 2011, 17( 8): 983- 988. DOI: 10.1038/nm.2426.
|
[35] |
MA L, ZHANG LW, DAI J, et al. Dysregulated TFR and TFH cells correlate with B-cell differentiation and antibody production in autoimmune hepatitis[J]. J Cell Mol Med, 2020, 24( 7): 3948- 3957. DOI: 10.1111/jcmm.14997.
|
[36] |
MA L, ZHANG LW, SONG JG, et al. Fecal microbiota transplantation controls progression of experimental autoimmune hepatitis in mice by modulating the TFR/TFH immune imbalance and intestinal microbiota composition[J]. Front Immunol, 2021, 12: 728723. DOI: 10.3389/fimmu.2021.728723.
|